Cancer-associated thrombosis and bleeding
International Journal of Hematology · 2024
DOI: 10.1007/s12185-024-03716-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Hematology, 2024. Verfasst von Takayuki Ikezoe. Beteiligte Einrichtung: Department of Hematology, Fukushima Medical University, Hikarigaoka 1, Fukushima, Fukushima, 960-1295, Japan. ikezoet@fmu.ac.jp. Hauptthemen laut MEDLINE: Thrombosis, Neoplasms, Anticoagulants, Hemorrhage. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Development of thrombosis is closely associated with poor prognosis in cancer patients. Cancer patients often fulfill Virchow's triad of hyper-coagulable state, vascular endothelial injury, and venous stasis. Cancer cells aberrantly express a variety of procoagulant factors, including tissue factor and podoplanin. Chemotherapeutic agents and radiation cause vascular endothelial injury, and reduced daily activity and bed rest for chemotherapy lead to venous stasis. Due to these factors, cancer patients are at high risk of developing thrombosis. Cancer patients are also at high risk of bleeding when they have disseminated intravascular coagulation and/or chemotherapy-induced thrombocytopenia as complications. International societies, such as the American Society of Clinical Oncology and the International Initiative on Thrombosis and Cancer (ITAC), have published clinical guidelines to help physicians better manage cancer-associated thrombosis (CAT). These guidelines recommend use of low molecular weight heparin or direct oral anticoagulants for the prevention of CAT, but unfortunately use of these drugs is not approved in Japan. This gap between Japan and other countries needs to be closed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Fukushima Medical University, Hikarigaoka 1, Fukushima, Fukushima, 960-1295, Japan. ikezoet@fmu.ac.jp.
Zitieren
APA
Ikezoe, T. (2024). Cancer-associated thrombosis and bleeding. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03716-0
Vancouver
Ikezoe T. Cancer-associated thrombosis and bleeding. International Journal of Hematology. 2024. doi:10.1007/s12185-024-03716-0
BibTeX
@article{Ikezoe2024,
author = {Ikezoe, Takayuki},
title = {Cancer-associated thrombosis and bleeding},
journal = {International Journal of Hematology},
year = {2024},
doi = {10.1007/s12185-024-03716-0}
}
EUVIMED